BrainsWay Ltd. (TLV: BWAY)

Market Cap	663.82M
Revenue (ttm)	143.60M
Net Income (ttm)	5.58M
Shares Out	37.59M
EPS (ttm)	0.16
PE Ratio	107.54
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	120,330
Open	1,728.00
Previous Close	1,815.00
Day's Range	1,690.00 - 1,775.00
52-Week Range	849.70 - 2,056.00
Beta	0.38
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About BrainsWay

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases. The company serves do...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 134
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: BWAY

Financial Performance

In 2023, BrainsWay's revenue was $31.79 million, an increase of 16.96% compared to the previous year's $27.18 million. Losses were -$4.20 million, -68.56% less than in 2022.

Financial numbers in USD